Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy

Christian Templin, Martin Meyer, Maja Franziska Müller, Valentin Djonov, Ruslan Hlushchuk, Ivanka Dimova, Stefanie Flueckiger, Peter Kronen, Michele Sidler, Karina Klein, Flora Nicholls, Jelena-Rima Ghadri, Klaus Weber, Dragica Paunovic, Roberto Corti, Simon P Hoerstrup, Thomas F Lüscher, Ulf Landmesser, Christian Templin, Martin Meyer, Maja Franziska Müller, Valentin Djonov, Ruslan Hlushchuk, Ivanka Dimova, Stefanie Flueckiger, Peter Kronen, Michele Sidler, Karina Klein, Flora Nicholls, Jelena-Rima Ghadri, Klaus Weber, Dragica Paunovic, Roberto Corti, Simon P Hoerstrup, Thomas F Lüscher, Ulf Landmesser

Abstract

Aims: Coronary late stent thrombosis, a rare but devastating complication, remains an important concern in particular with the increasing use of drug-eluting stents. Notably, pathological studies have indicated that the proportion of uncovered coronary stent struts represents the best morphometric predictor of late stent thrombosis. Intracoronary optical frequency domain imaging (OFDI), a novel second-generation optical coherence tomography (OCT)-derived imaging method, may allow rapid imaging for the detection of coronary stent strut coverage with a markedly higher precision when compared with intravascular ultrasound, due to a microscopic resolution (axial approximately 10-20 microm), and at a substantially increased speed of image acquisition when compared with first-generation time-domain OCT. However, a histological validation of coronary OFDI for the evaluation of stent strut coverage in vivo is urgently needed. Hence, the present study was designed to evaluate the capacity of coronary OFDI by electron (SEM) and light microscopy (LM) analysis to detect and evaluate stent strut coverage in a porcine model.

Methods and results: Twenty stents were implanted into 10 pigs and coronary OFDI was performed after 1, 3, 10, 14, and 28 days. Neointimal thickness as detected by OFDI correlated closely with neointimal thickness as measured by LM (r = 0.90, P < 0.01). The comparison of stent strut coverage as detected by OFDI and SEM analysis revealed an excellent agreement (r = 0.96, P < 0.01). In particular, stents completely covered by OFDI analysis were also completely covered by SEM analysis. All incompletely covered stents by OFDI were also incompletely covered by SEM. Analyses of fibrin-covered stent struts suggested that these may rarely be detected as uncovered stent struts by OFDI. Importantly, optical density measurements revealed a significant difference between fibrin- and neointima-covered coronary stent struts [0.395 (0.35-0.43) vs. 0.53 (0.47-0.57); P < 0.001], suggesting that differences in optical density provide information on the type of stent strut coverage. The sensitivity and specificity for detection of fibrin vs. neointimal coverage was evaluated using receiver-operating characteristic analysis.

Conclusion: The present study demonstrates that OFDI is a highly promising tool for accurate evaluation of coronary stent strut coverage, as supported by a high agreement between OFDI and light and electron microscopic analysis. Furthermore, our data indicate that optical density measurements can provide additional information with respect to the type of stent strut coverage, i.e. fibrin vs. neointimal coverage. Therefore, coronary OFDI analysis will provide important information on the biocompatibility of coronary stents.

Figures

Figure 1
Figure 1
Representative corresponding images of scanning electron microscopy (SEM) and optical frequency domain imaging (OFDI) analysis of the same stent segment. (A) Overview in SEM; (B) details of the side-branch in SEM; (C) overview in OFDI; (DG) sequential OFDI images showing covered and uncovered stent struts corresponding to the marked positions in the electron microscopy image in (B); (F) shows one strut covered (upper) and one strut blank (lower) as seen on the SEM image as well.
Figure 2
Figure 2
Different characteristics of stent strut coverage at different time points after stent implantation, i.e. fibrin- vs. neointima-covered stent struts. (A) Fibrin at Day 3 in scanning electron microscopy (SEM) and optical frequency domain imaging (OFDI), where a low intensity of stent strut coverage can be seen (A‴′); (B) neointima at Day 10 in SEM and OFDI, where stent strut coverage with higher intensity when compared with fibrin can be observed; (C) neointima at Day 28 in SEM and OFDI, where a high intensity of stent strut coverage is present (is, intensity of strut; it, intensity of tissue).
Figure 3
Figure 3
Assessment of the optical density of the optical frequency domain imaging (OFDI) images of stent strut coverage—differences between fibrin vs. neointimal stent strut coverage. (A) Densitometric analysis of OFDI images with histologically approved fibrin- and neointima-covered stent struts (medians with interquartile ranges); (B) receiver-operating characteristic curve of data presented in (A); (C) densitometric analysis of the development of neointimal coverage of stents at different time points after stent implantation.
Figure 4
Figure 4
Relation of measurements of neointimal thickness between light microscopic (LM) and optical frequency domain imaging (OFDI) analysis on Days 10–28 after coronary stent implantation. Dot plot (A) and log transformation of Bland–Altman plot (B; red lines = limit of agreements) are shown demonstrating the agreement between neointimal thickness measurements obtained by light microscopy and OFDI analysis.
Figure 5
Figure 5
Corresponding images of light microscopic (LM) and optical frequency domain imaging (OFDI) analysis of neointima measurements. The image wire and the guide wire shadow have been marked in OFDI (white) and on their corresponding sites in LM (black), matching pairs were found as positions of LM images in the stent were known and positions of OFDI images could be calculated from the number of images between start and end of the stent. (A) Day 3, one strut on OFDI is hidden behind the guide wire shadow, one is hidden behind the image wire shadow (indicated by asterisks); (B) Day 14, again, one strut is hidden behind the guide wire shadow in the OFDI image (asterisks); (C) Day 28 LM vs. OFDI, all struts are visible in OFDI and LM images, measurement of neointimal thickness is marked in red.

References

    1. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, Brodie B, Hannan E, Harjai K, Jensen LO, Park SJ, Perry R, Racz M, Saia F, Tu JV, Waksman R, Lansky AJ, Mehran R, Stone GW. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation. 2009;119:3198–3206. .
    1. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126–2130. .
    1. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364:1519–1521. .
    1. Moreno R, Fernandez C, Hernandez R, Alfonso F, Angiolillo DJ, Sabate M, Escaned J, Banuelos C, Fernandez-Ortiz A, Macaya C. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol. 2005;45:954–959. .
    1. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Juni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667–678. .
    1. Wenaweser P, Daemen J, Zwahlen M, van Domburg R, Juni P, Vaina S, Hellige G, Tsuchida K, Morger C, Boersma E, Kukreja N, Meier B, Serruys PW, Windecker S. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol. 2008;52:1134–1140. .
    1. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115:2435–2441. .
    1. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193–202. .
    1. Luscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, Virmani R. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation. 2007;115:1051–1058. .
    1. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109:701–705. .
    1. Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, Sawada T, Paredes OL, Hirata K, Yokoyama M. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J. 2007;28:961–967. .
    1. Takano M, Yamamoto M, Inami S, Murakami D, Seimiya K, Ohba T, Seino Y, Mizuno K. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist? J Am Coll Cardiol. 2008;51:968–969. .
    1. Gonzalo N, Barlis P, Serruys PW, Garcia-Garcia HM, Onuma Y, Ligthart J, Regar E. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography. JACC Cardiovasc Interv. 2009;2:445–452. .
    1. Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, Gold HK, Burke AP, Kolodgie FD, Virmani R. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation. 2008;118:1138–1145. .
    1. Tearney GJ, Waxman S, Shishkov M, Vakoc BJ, Suter MJ, Freilich MI, Desjardins AE, Oh WY, Bartlett LA, Rosenberg M, Bouma BE. Three-dimensional coronary artery microscopy by intracoronary optical frequency domain imaging. JACC Cardiovasc Imaging. 2008;1:752–761. .
    1. Yun SH, Tearney GJ, Vakoc BJ, Shishkov M, Oh WY, Desjardins AE, Suter MJ, Chan RC, Evans JA, Jang IK, Nishioka NS, de Boer JF, Bouma BE. Comprehensive volumetric optical microscopy in vivo. Nat Med. 2006;12:1429–1433. .
    1. Okamura T, Serruys PW, Regar E. Three-dimensional visualization of intracoronary thrombus during stent implantation using the second generation, Fourier domain optical coherence tomography. Eur Heart J. 2010;31:625. .
    1. Makanya AN, Hlushchuk R, Baum O, Velinov N, Ochs M, Djonov V. Microvascular endowment in the developing chicken embryo lung. Am J Physiol Lung Cell Mol Physiol. 2007;292:L1136–L1146. .
    1. Makanya AN, Djonov V. Development and spatial organization of the air conduits in the lung of the domestic fowl, Gallus gallus variant domesticus. Microsc Res Tech. 2008;71:689–702. .
    1. Cheneau E, John MC, Fournadjiev J, Chan RC, Kim HS, Leborgne L, Pakala R, Yazdi H, Ajani AE, Virmani R, Waksman R. Time course of stent endothelialization after intravascular radiation therapy in rabbit iliac arteries. Circulation. 2003;107:2153–2158. .
    1. Donath K. Preparation of Histologic Sections by the Cutting-Grinding Technique for Hard Tissues and other Material. Norderstedt: 1993.
    1. Prati F, Zimarino M, Stabile E, Pizzicannella G, Fouad T, Rabozzi R, Filippini A, Pizzicannella J, Cera M, De Caterina R. Does optical coherence tomography identify arterial healing after stenting? An in vivo comparison with histology, in a rabbit carotid model. Heart. 2008;94:217–221. .
    1. Marano RJ, Rakoczy PE. An improved method using densitometry for evaluating severity of laser photocoagulation induced CNV. Biotech Histochem. 2006;81:59–62. .
    1. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–310.
    1. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol. 2007;27:1500–1510. .
    1. Matter CM, Rozenberg I, Jaschko A, Greutert H, Kurz DJ, Wnendt S, Kuttler B, Joch H, Grunenfelder J, Zund G, Tanner FC, Luscher TF. Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol. 2006;48:286–292. .
    1. Schwartz RS, Edelman ER, Carter A, Chronos N, Rogers C, Robinson KA, Waksman R, Weinberger J, Wilensky RL, Jensen DN, Zuckerman BD, Virmani R. Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation. 2002;106:1867–1873. .

Source: PubMed

3
Předplatit